Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. (BOMPA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01218607
Recruitment Status : Completed
First Posted : October 11, 2010
Last Update Posted : March 5, 2014
Information provided by (Responsible Party):
Alexander Van De Bruaene, Universitaire Ziekenhuizen Leuven

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2014
  Actual Study Completion Date : March 2014